Related Experiment Videos

Eye malformations associated with treatment with carbamazepine during pregnancy

A G Sutcliffe1, R B Jones, G Woodruff

  • 1Department of Pediatrics, Moorfields Eye Hospital, London, UK.

Ophthalmic Genetics
|August 8, 1998
PubMed

Insights

Carbamazepine exposure during pregnancy may cause severe eye malformations in children, including anophthalmos, microphthalmos, and optic disc coloboma. This highlights the potential teratogenic effects of this medication on fetal ocular development.

Area of Science:

  • Ophthalmology
  • Teratology
  • Pediatric Medicine

Background:

  • Anticonvulsant medications are frequently used during pregnancy.
  • Carbamazepine is a common treatment for epilepsy and bipolar disorder.
  • Understanding medication risks during gestation is crucial for prenatal care.

Observation:

  • Four pediatric cases presented with congenital eye malformations.
  • Observed conditions included bilateral anophthalmos, bilateral severe microphthalmos, and unilateral optic disc coloboma.
  • Maternal history revealed carbamazepine treatment during pregnancy for all four cases.

Findings:

  • A potential association between prenatal carbamazepine exposure and severe ocular abnormalities is suggested.
  • The specific malformations observed (anophthalmos, microphthalmos, optic disc coloboma) indicate a possible teratogenic impact on eye development.
  • Carbamazepine's teratogenic potential warrants further investigation in the context of congenital eye defects.

Implications:

  • Clinicians should consider carbamazepine's potential teratogenic effects when managing pregnant patients.
  • Prenatal counseling regarding anticonvulsant risks is essential.
  • Further research is needed to confirm the causal link and elucidate the mechanisms of carbamazepine-induced ocular teratogenesis.

Related Concept Videos